Will New VYKAT XR Safety Details and Q2 Update Shift Soleno Therapeutics' (SLNO) Story? - simplywall.st
21 hours ago • Google News
Soleno Therapeutics Inc (SLNO)
US$ 73.26-1.31%
Price Chart
Key Statistics
Market Cap
$ 4.54B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
774.87K
52W High
$ 90.32
52W Low
$ 41.50
Dividend Yield
0.00%
Beta
-2.63
Technicals
50-Day MA
81.6814
200-Day MA
61.9435
52 Week High
90.3199
52 Week Low
41.5
About SLNO
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Employees
115
Headquarters
Redwood City, CA
CEO
Dr. Anish Bhatnagar M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg